Astellas Withdraws Izervay’s European Approval Filing

 
• By Lisa Takagi
  
Izervay's European approval was withdrawn by Astellas after its interactions with CHMP. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from EU CHMP

More from Product Reviews